{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:08:08Z","timestamp":1782263288571,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.beem.2011.11.006","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T20:03:53Z","timestamp":1337717033000},"page":"485-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Subclinical primary aldosteronism"],"prefix":"10.1016","volume":"26","author":[{"given":"Yuji","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoyu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2011.11.006_bib1","first-page":"6","article-title":"Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/j.beem.2011.11.006_bib2","first-page":"213","article-title":"Suppression of plasma renin activity in primary aldosteronism","volume":"190","author":"Conn","year":"1964","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.beem.2011.11.006_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0002-9610(64)90249-1","article-title":"Present status of pathology of adrenal gland in hypertension","volume":"107","author":"Sherwin","year":"1964","journal-title":"American Journal of Surgery"},{"key":"10.1016\/j.beem.2011.11.006_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2011.11.006_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/HYPERTENSIONAHA.106.086116","article-title":"Is there an unrecognized epidemic of primary aldosteronism?","volume":"50","author":"Calhoun","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib6","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.11.006_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1507\/endocrj.KR-105","article-title":"Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication?","volume":"54","author":"Nishikawa","year":"2007","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.beem.2011.11.006_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bmj.1.5794.220","article-title":"Hypealdosteronism from adrenal carcinoma","volume":"1","author":"Brooks","year":"1972","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2011.11.006_bib10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bmj.1.6018.1125-a","article-title":"Normotensive primary aldosteronism","volume":"1","author":"Snow","year":"1976","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2011.11.006_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-88-5-655","article-title":"Normotensive primary aldosteronism","volume":"88","author":"Zipser","year":"1978","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2011.11.006_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0002-9343(80)90474-X","article-title":"Normotensive primary aldosteronism","volume":"69","author":"Shiroto","year":"1980","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.beem.2011.11.006_bib13","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3109\/10641968109037428","article-title":"A case of normoreninenic, normotensive primary aldosteronism associated with essential hypertension and nephrocalcinosis","volume":"3","author":"Ogihara","year":"1981","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1210\/jcem-52-5-1009","article-title":"Normotensive primary aldosteronism: report of a case","volume":"52","author":"Kono","year":"1981","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.11.006_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.HYP.5.2.240","article-title":"Asymptomatic normotensive primary aldosteronism. Case report","volume":"5","author":"Matsunaga","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1507\/endocrj1954.31.159","article-title":"A case of normotensive primary aldosteronism \u2013 comparison with 13 previously experienced cases with hypertension","volume":"31","author":"Nishimiya","year":"1984","journal-title":"Endocrinologia Japonica"},{"key":"10.1016\/j.beem.2011.11.006_bib17","first-page":"797","article-title":"A case of normotensive primary aldosteronism with hypopituitarism, epilepsy, and medullary sponge kidney","volume":"121","author":"Kuroda","year":"1989","journal-title":"Acta Endocrinologica (Copenhagen)"},{"key":"10.1016\/j.beem.2011.11.006_bib18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1507\/endocrj1954.36.817","article-title":"Normotensive glucocorticoid\u2013suppressible hyperaldosteronism in adult","volume":"36","author":"Maeda","year":"1989","journal-title":"Endocrinologia Japonica"},{"key":"10.1016\/j.beem.2011.11.006_bib19","article-title":"Primary hyperaldosteronism without arterial hypertension","volume":"114","author":"Osterziel","year":"1989","journal-title":"Deutsche medizinische Wochenschrift"},{"key":"10.1016\/j.beem.2011.11.006_bib20","first-page":"1139","article-title":"A case of normotensive primary aldosteronism in association with non-functioning adenoma and aldosterone producing adenoma in ipsilateral gland","volume":"85","author":"Akiyama","year":"1994","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"10.1016\/j.beem.2011.11.006_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000045045","article-title":"Normotensive primary aldosteronism due to adrenocortical carcinoma","volume":"79","author":"Muthusethupathi","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.beem.2011.11.006_bib22","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0022-5347(01)61656-2","article-title":"Primary aldosteronism due to aldosterone producing adenoma without hypertension","volume":"161","author":"Suzuki","year":"1999","journal-title":"Journal of Urology"},{"key":"10.1016\/j.beem.2011.11.006_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.0.1410279","article-title":"Aldosterone-producing adenoma without hypertension: a report of two cases","volume":"141","author":"Vantyghem","year":"1999","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.11.006_bib24","first-page":"492","article-title":"Hypokalemic quadriparesis with normotensive primary hyperaldosteronism","volume":"14","author":"Talib","year":"2004","journal-title":"Journal of the College of Physicians and Surgeons\u2013Pakistan"},{"key":"10.1016\/j.beem.2011.11.006_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2265.2008.03213.x","article-title":"Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases","volume":"69","author":"M\u00e9deau","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2011.11.006_bib26","first-page":"1","article-title":"Normotensive primary aldosteronism: a case report","volume":"5","author":"Kanoun","year":"2009","journal-title":"The Internet Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.11.006_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/EJE-09-0271","article-title":"Coexistence of normotensive primary aldosteronism in two patients with Gitelman\u2019s syndrome and novel thiazide-sensitive Na\u2013Cl cotransporter mutations","volume":"161","author":"Miao","year":"2009","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.beem.2011.11.006_bib28","first-page":"2160","article-title":"Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance","volume":"85","author":"Stowasser","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.11.006_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib30","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.11.006_bib31","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.beem.2011.11.006_bib32","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2011.11.006_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib34","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.11.006_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/hr.2010.166","article-title":"Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects","volume":"34","author":"Ito","year":"2011","journal-title":"Hypertension Research"},{"key":"10.1016\/j.beem.2011.11.006_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2011.11.006_bib37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/HYPERTENSIONAHA.107.091785","article-title":"Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring","volume":"50","author":"Ojeda","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib38","first-page":"1476","article-title":"Brain natriuretic peptide is synthesized in the human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism","volume":"79","author":"Lee","year":"1994","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.11.006_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/hr.2010.206","article-title":"Does primary aldosteronism exist in normotensive and mildly hypertensive patients, and should we look for it?","volume":"34","author":"Rossi","year":"2011","journal-title":"Hypertension Research"},{"key":"10.1016\/j.beem.2011.11.006_bib40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2005.02229.x","article-title":"Mineralocorticoid resistance","volume":"62","author":"Geller","year":"2005","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2011.11.006_bib41","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1523-1755.2000.00969.x","article-title":"Physiologic resistance to the action of aldosterone","volume":"57","author":"Stokes","year":"2000","journal-title":"Kidney International"},{"key":"10.1016\/j.beem.2011.11.006_bib42","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.amjhyper.2007.08.006","article-title":"Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts","volume":"20","author":"Antonello","year":"2007","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib43","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/jc.2004-1149","article-title":"The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling","volume":"90","author":"Tiu","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.11.006_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.beem.2011.11.006_bib46","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib47","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/01.HYP.0000014324.68506.CA","article-title":"Diagnostic value of the post-captopril test in primary aldosteronism","volume":"39","author":"Castro","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib48","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","article-title":"Captopril suppression versus salt loading in confirming primary aldosteronism","volume":"37","author":"Agharazii","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1536\/ihj.26.549","article-title":"Clinical evaluation of the captopril screening test for primary aldosteronism","volume":"26","author":"Naomi","year":"1985","journal-title":"Japanese Heart Journal"},{"key":"10.1016\/j.beem.2011.11.006_bib50","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ajh\/6.11.899","article-title":"The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension","volume":"6","author":"Iwaoka","year":"1993","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan","volume":"18","author":"Takeda","year":"1995","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2011.11.006_bib52","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Millez","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.beem.2011.11.006_bib53","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2011.11.006_bib54","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2011.11.006_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/hr.2010.202","article-title":"Should primary aldosteronism be diagnosed among normotensive subjects during general health check-up and\/or at general outpatient clinics?","volume":"34","author":"Nishikawa","year":"2011","journal-title":"Hypertension Research"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X11001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:46:08Z","timestamp":1761497168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X11001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1521690X11001539"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2011.11.006","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2011.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}